These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2420968)

  • 81. KININASE INHIBITION BY A FLUORESCENT SUBSTANCE PREPARED FROM LIVER.
    AMUNDSEN E; WAALER BA; DEDICHEN J; LALAND P; LALAND S; THORSDALEN N
    Nature; 1964 Sep; 203():1245-8. PubMed ID: 14230200
    [No Abstract]   [Full Text] [Related]  

  • 82. [EVALUATION WITH RADIOSODIUM OF THE LOCAL VASOACTIVE EFFECT OF ANGIOTENSIN AND BRADYKININ INJECTED BY THE INTRADERMAL ROUTE].
    KUSCHNIR E; MOSCONE RO; BRAUNSTEIN NA; MOYANO AF; CORCOBA C; GUTIERREZ E
    Medicina (B Aires); 1964; 24():227-30. PubMed ID: 14183492
    [No Abstract]   [Full Text] [Related]  

  • 83. Ineffectiveness of carboxypeptidase B in inhibiting the pressor effect of incubated human plasma.
    Croxatto H; Cruzatt H
    Experientia; 1969 Jan; 25(1):59-60. PubMed ID: 5766583
    [No Abstract]   [Full Text] [Related]  

  • 84. Kininase activity in human blood.
    Watanabe N; Abe K; Kumagai N; Mouri T; Seki T; Yoshinaga K
    Tohoku J Exp Med; 1966 Aug; 89(4):383-6. PubMed ID: 5969555
    [No Abstract]   [Full Text] [Related]  

  • 85. Potentiation of bradykinin by dimercaptopropanol (bal) and other inhibitors of its destroying enzyme in plasma.
    FERREIRA SH; ROCHA E SILVA M
    Biochem Pharmacol; 1962 Dec; 11():1123-8. PubMed ID: 13944892
    [No Abstract]   [Full Text] [Related]  

  • 86. Inhibition of plasma kininase activity at slightly acid ph.
    Edery H; Lewis GP
    Br J Pharmacol Chemother; 1962 Oct; 19(2):299-305. PubMed ID: 19108167
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Second kininase in human blood plasma.
    Yang HY; Erdös EG
    Nature; 1967 Sep; 215(5108):1402-3. PubMed ID: 6055465
    [No Abstract]   [Full Text] [Related]  

  • 88. Kininase activity in experimental pancreatitis.
    Nugent FW; Atendido WA; Bulan MB; MacDonald AJ
    Nature; 1966 Jul; 211(5045):207-8. PubMed ID: 5966312
    [No Abstract]   [Full Text] [Related]  

  • 89. Kininase activity in human blood in normal and pathological conditions.
    Watanabe N
    Tohoku J Exp Med; 1967 May; 92(1):63-72. PubMed ID: 6059661
    [No Abstract]   [Full Text] [Related]  

  • 90. Kininase activity in asthmatic serum.
    Tewksbury DA; Marschke GR
    Int Arch Allergy Appl Immunol; 1966; 30(6):538-41. PubMed ID: 5961124
    [No Abstract]   [Full Text] [Related]  

  • 91. Influence of metals on the activity of a bradykinin-destroying enzyme kininase.
    Aarsen PN; Kemp A
    Br J Pharmacol Chemother; 1962 Dec; 19(3):442-50. PubMed ID: 19108170
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Assay of kininase activity in human blood.
    Abe K; Watanabe N; Kumagai N; Miwa I; Mouri K; Seki T; Oikawa A; Yoshinaga K
    Tohoku J Exp Med; 1965 Jun; 86(1):77-83. PubMed ID: 5830872
    [No Abstract]   [Full Text] [Related]  

  • 93. The release of vasoactive substances in acute pancreatitis.
    THAL AP; KOBOLD EE; HOLLENBERG MJ
    Am J Surg; 1963 Jun; 105():708-13. PubMed ID: 13980815
    [No Abstract]   [Full Text] [Related]  

  • 94. Bradykinin B2 Receptor Signaling Increases Glucose Uptake and Oxidation: Evidence and Open Questions.
    Gregnani MF; Hungaro TG; Martins-Silva L; Bader M; Araujo RC
    Front Pharmacol; 2020; 11():1162. PubMed ID: 32848770
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Kininase 1 As a Preclinical Therapeutic Target for Kinin B
    Haddad Y; Couture R
    Front Pharmacol; 2017; 8():509. PubMed ID: 28824433
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Effect of DL-2-mercaptomethyl-3-guanidinoethylthiopropanoic acid on the blood pressure response to vasoactive substances.
    Salgado HC; Carretero OA; Scicli AG; Murray RD
    J Pharmacol Exp Ther; 1986 Apr; 237(1):204-8. PubMed ID: 2420968
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Effects of combined neutral endopeptidase 24-11 and angiotensin-converting enzyme inhibition on femoral vascular conductance in streptozotocin-induced diabetic rats.
    Arbin V; Claperon N; Fournié-Zaluski MC; Roques BP; Peyroux J
    Br J Pharmacol; 2000 Jul; 130(6):1297-304. PubMed ID: 10903969
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Contributions of various rat plasma peptidases to kinin hydrolysis.
    Ishida H; Scicli AG; Carretero OA
    J Pharmacol Exp Ther; 1989 Dec; 251(3):817-20. PubMed ID: 2557417
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Role of renal endopeptidase 24.11 in kinin metabolism in vitro and in vivo.
    Ura N; Carretero OA; Erdös EG
    Kidney Int; 1987 Oct; 32(4):507-13. PubMed ID: 2828746
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.